BioCube, Inc.
BICB
Get informed when a big investor buys or sells
+ FollowMarket Cap$9.67K
Close$
$0.00
0% upside
Current Fair Value
0% upsideOvervalued by 0% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $9,674.00 |
|---|---|
| Enterprise Value | $6,703.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $0 |
| Beta | 1.2 |
| Outstanding Shares | 96,742,758 |
Return
| Return on Equity | -1852.91% |
|---|---|
| Return on Assets | -583.84% |
| Return on Invested Capital | -5410.31% |
Valuation & Multiples
| P/E Ratio | -0.2 |
|---|---|
| PEG | -17.63 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0.07 |
| Enterprise Value to EBIT | -0.04 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.92 |
| Debt to Equity | 1.79 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About BioCube, Inc.
18 employees
CEO: Paul Lisak BioCube, Inc. is an emerging company primarily engaged in the research, development, and commercialization of lithium-ion batteries throughout North America. The organization, which officially became BioCube, Inc. in December 2010, was p...